Carson Wealth (CWM LLC)
PLRX icon

Carson Wealth (CWM LLC)’s Pliant Therapeutics PLRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267 Sell
212
-179
-46% -$226 ﹤0.01% 5506
2025
Q4 		$0 Sell
391
-266
-40% -$400 ﹤0.01% 5574
2025
Q3 		$1K Sell
657
-2,643
-80% -$4.03K ﹤0.01% 5173
2025
Q2 		$4K Sell
3,300
-5,225
-61% -$7.38K ﹤0.01% 4706
2025
Q1 		$12K Buy
8,525
+7,918
+1,304% +$48.1K ﹤0.01% 4016
2024
Q4 		$8K Buy
607
+128
+27% +$1.75K ﹤0.01% 4006
2024
Q3 		$5K Buy
+479
New +$5.99K ﹤0.01% 4130
2024
Q2 		– Sell
-1
Closed – – 4859
2024
Q1 		$0 Buy
+1
New +$16 ﹤0.01% 4647
2023
Q4 		– Sell
-7
Closed – – 4430
2023
Q3 		$0 Buy
+7
New +$121 ﹤0.01% 4460

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Carson Wealth (CWM LLC)'s PLRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Pliant Therapeutics (PLRX) stake by 46% in Q1 2026, selling an estimated $226 and leaving 212 shares worth $267. The position accounts for ﹤0.01% of the portfolio, ranked #5506.

Carson Wealth (CWM LLC) first reported a position in PLRX in Q3 2023 and has held it in 9 quarters since. The position peaked at $12K in Q1 2025. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 212 shares of Pliant Therapeutics worth $267 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 179 Pliant Therapeutics shares in Q1 2026, an estimated $226.
  • Pliant Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5506 holding.
  • Carson Wealth (CWM LLC) first reported a position in Pliant Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s Pliant Therapeutics position peaked at $12K in Q1 2025.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.